Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial

Journal:

Nature Communications

Published:

2026-06-17

DOI:

10.1038/s41467-026-74570-3

Affiliations:

13

Authors:

21

Go to article

Institutions	Authors	Share
Netherlands Cancer Institute (NKI), Netherlands	15.000000 15.000000	0.71
University Medical Center Groningen (UMCG), RUG, Netherlands	2.000000	0.10
Houston Methodist Neal Cancer Center, United States of America (USA)	1.000000	0.05
Houston Methodist Research Institute, United States of America (USA)	1.000000	0.05
Oncode Institute, Netherlands	1.000000	0.05
University Medical Center Utrecht (UMC Utrecht), Netherlands	1.000000	0.05